Cidara Therapeutics (CDTX) Short Interest Ratio & Short Volume → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free CDTX Stock Alerts $12.70 +0.54 (+4.44%) (As of 04:27 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Cidara Therapeutics Short Interest DataCurrent Short Volume83,700 sharesPrevious Short Volume8,200 sharesChange Vs. Previous Month+920.73%Dollar Volume Sold Short$1.00 millionShort Interest Ratio / Days to Cover1.4Last Record DateApril 30, 2024Outstanding Shares4,560,000 sharesFloat Size4,110,000 sharesShort Percent of Float2.04%Today's Trading Volume14,488 sharesAverage Trading Volume51,102 sharesToday's Volume Vs. Average28% Short Selling Cidara Therapeutics ? Sign up to receive the latest short interest report for Cidara Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCDTX Short Interest Over TimeCDTX Days to Cover Over TimeCDTX Percentage of Float Shorted Over Time Ad InvestorPlaceMillionaire investor and Republican donor makes surprising election predictionFind out who Louis believes is going to win the election... And why that will launch a second boom in AI stocksClick for his six specific AI stock in the crosshairs Cidara Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202483,700 shares $1.00 million +920.7%2.0%1.4 $11.98 4/15/20248,200 shares $135,250.80 -95.8%N/A0.2 $16.49 3/31/2024195,400 shares $179,768.00 +8.9%N/A0.3 $0.92 3/15/2024179,500 shares $122,939.55 -18.9%N/A0.3 $0.68 2/29/2024221,400 shares $156,640.50 -52.2%N/A0.3 $0.71 2/15/2024463,300 shares $320,742.59 -22.1%N/A0.7 $0.69 Get the Latest News and Ratings for CDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024594,500 shares $381,193.40 -4.7%N/A0.9 $0.64 1/15/2024623,800 shares $477,830.80 -38.8%N/A1.1 $0.77 12/31/20231,020,000 shares $809,880.00 +44.3%N/A1.8 $0.79 12/15/2023707,100 shares $505,930.05 -23.6%N/A1.3 $0.72 11/30/2023925,600 shares $656,620.64 -24.8%N/A2.7 $0.71 11/15/20231,230,000 shares $953,250.00 -0.8%N/A2.8 $0.78 10/31/20231,240,000 shares $951,080.00 -6.1%N/A2.7 $0.77 10/15/20231,320,000 shares $1.21 million -12.0%N/A2.6 $0.92 9/30/20231,500,000 shares $1.41 million -3.9%N/A2.6 $0.94 9/15/20231,560,000 shares $1.67 million +31.1%N/A2.6 $1.07 8/31/20231,190,000 shares $933,079.00 -16.2%N/A1.8 $0.78 8/15/20231,420,000 shares $1.29 million -8.4%N/A2.3 $0.91 7/31/20231,550,000 shares $1.54 million -4.9%N/A1.8 $1.00 7/15/20231,630,000 shares $1.79 million -6.9%N/A1.7 $1.10 6/30/20231,750,000 shares $1.98 million +17.5%N/A1.6 $1.13 6/15/20231,490,000 shares $1.70 million -22.0%N/A0.8 $1.14 5/31/20231,910,000 shares $2.54 million -14.0%N/A0.7 $1.33 5/15/20232,220,000 shares $3.02 million -7.9%N/A0.7 $1.36 4/30/20232,410,000 shares $2.46 million -21.8%N/A0.8 $1.02 4/15/20233,080,000 shares $3.33 million -13.2%N/A0.9 $1.08 3/31/20233,550,000 shares $4.51 million +63.6%N/A1 $1.27 3/15/20232,170,000 shares $3.65 million -30.0%N/A0.7 $1.68 2/28/20233,100,000 shares $4.68 million +56.6%N/A1.6 $1.51 2/15/20231,980,000 shares $3.15 million +13.1%N/A1.4 $1.59 1/31/20231,750,000 shares $2.15 million +141.3%N/A1.4 $1.23 1/15/2023725,200 shares $957,264.00 +27.9%N/A1.2 $1.32 12/30/2022567,100 shares $428,897.73 -7.1%N/A1.8 $0.76 12/15/2022610,200 shares $305,038.98 +12.8%N/A2.2 $0.50 11/30/2022540,900 shares $346,230.09 -25.3%N/A2.2 $0.64 11/15/2022724,300 shares $452,542.64 +45.6%N/A3 $0.62 10/31/2022497,400 shares $305,901.00 +22.7%N/A1.9 $0.62 10/15/2022405,300 shares $226,886.94 -11.2%N/A0.9 $0.56 9/30/2022456,500 shares $286,682.00 -23.2%N/A1 $0.63 9/15/2022594,400 shares $428,740.72 -0.8%N/A1.2 $0.72Millionaire investor and Republican donor makes surprising election prediction (Ad)Find out who Louis believes is going to win the election... And why that will launch a second boom in AI stocksClick for his six specific AI stock in the crosshairs CDTX Short Interest - Frequently Asked Questions What is Cidara Therapeutics' current short interest? Short interest is the volume of Cidara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 83,700 shares of CDTX short. 2.04% of Cidara Therapeutics' shares are currently sold short. Learn More on Cidara Therapeutics' current short interest. What is a good short interest ratio for Cidara Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CDTX shares currently have a short interest ratio of 1.0. Learn More on Cidara Therapeutics's short interest ratio. Which institutional investors are shorting Cidara Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cidara Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cidara Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.04% of Cidara Therapeutics' floating shares are currently sold short. Is Cidara Therapeutics' short interest increasing or decreasing? Cidara Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 83,700 shares, an increase of 920.7% from the previous total of 8,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cidara Therapeutics' float size? Cidara Therapeutics currently has issued a total of 4,560,000 shares. Some of Cidara Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cidara Therapeutics currently has a public float of 4,110,000 shares. How does Cidara Therapeutics' short interest compare to its competitors? 2.04% of Cidara Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cidara Therapeutics: Genenta Science S.p.A. (0.03%), Aligos Therapeutics, Inc. (1.11%), AVROBIO, Inc. (0.42%), Ikena Oncology, Inc. (5.99%), Turnstone Biologics Corp. (5.22%), Elutia Inc. (0.20%), Atara Biotherapeutics, Inc. (9.87%), Instil Bio, Inc. (0.19%), Precision BioSciences, Inc. (9.31%), Cognition Therapeutics, Inc. (0.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cidara Therapeutics stock? Short selling CDTX is an investing strategy that aims to generate trading profit from Cidara Therapeutics as its price is falling. CDTX shares are trading up $0.54 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cidara Therapeutics? A short squeeze for Cidara Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CDTX, which in turn drives the price of the stock up even further. How often is Cidara Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ENTX Short Interest GNTA Short Interest ALGS Short Interest AVRO Short Interest IKNA Short Interest TSBX Short Interest ELUT Short Interest ATRA Short Interest TIL Short Interest DTIL Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CDTX) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press